9 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26447940	27	Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.	Bar-Ilan University
24846781	14	Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(a or¿)-thio-(a,ß- orß,¿)-methylenetriphosphate scaffold.	Bar-Ilan University
23751098	24	Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.	Bar-Ilan University
23368907	62	Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.	Bristol-Myers Squibb Research And Development
16250663	8	Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.	University Of Bonn
12213051	207	Purine and pyrimidine (P2) receptors as drug targets.	National Institute Of Diabetes
11985476	35	Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.	National Institute Of Diabetes
11754592	21	Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.	National Institute Of Diabetes
21090681	18	Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.	Bar-Ilan University